and DNMT3B polymorphisms contribute to gout susceptibility. These polymorphisms were screened for in 336 gout patients and 306 healthy control subjects (from a South China population) for association with gout. The distribution frequencies of DNMT1 rs2228611 AA genotype (P=0.007) and A allele (P=0.002; odds ratio=1.508, 95% confidence �����v�l=1.158�1.964) w��� ����d �� b� ��g��fi����l� ��������d in the gout patients when compared with those in the healthy control subjects. The rs1550117 in DNMT3A and rs2424913 in DNMT3B �x��b���d �� ��g��fi���� ������������ w��� g��� susceptibility between the patients and control subjects. These results demonstrated that the DNMT1 rs2228611 polymorphism may be involved in the pathogenesis of gout, while DNMT3A rs1550117 and DNMT3B rs2424913 did not show any obvious ��g��fi����� �� ��� ������� ���d�; ����, ��� ��� b� ���d �� ���k factors to predict the susceptibility to gout. However, further studies are required to investigate the functions and regulatory mechanism of the polymorphisms of DNMTs in gout.
Introduction���� ��������� �� ��� ���� ������ ����������� ��d ������ disease affecting 1-2% of adults worldwide, which is associated with elevated serum urate levels and the deposition of monosodium urate (MSU) in the joints (1). Previous studies show that gout is also associated with the genetic background, a purine rich diet and alcohol consumption (2-4), and epidemiological studies have suggested that the prevalence and incidence of gout are increasing globally (5,6). Over the past decade, signif-����� �������fi� �dv����� ��v� b��� ��d� �� ��d������d��g ��� �����g������ ��d ��������� �� g���. B���g � ����l�x d������, ��� �d����fi������ �� g������ ��d ��v���������l ���k ������� ��� gout may facilitate with investigating the pathogenesis of gout. As with other diseases, epigenetic events or heritable changes �� g��� �x�������� �������� w������ DNA ��q����� �l��������� may be evaluated to gain insight into the concrete pathogenesis of gout (7). DNA methylation is the most common epigenetic ��d�fi������, ��d �� ��������� �� ������������� ��d ��� ����-matin structure (8). The process of DNA methylation usually occurs at the CpG sites and the methyl group to the 5' position of a cytosine in a CpG dinucleotide conferred by DNA methyltransferases (DNMTs) (9). Three primary DNMTs, DNMT1, DNMT3A ��d DNMT3B, ��� �������� gl�b�l DNA ����-ylation (10). In addition, DNMT1 is a primary enzyme for maintaining methylation patterns during DNA replication, whereas DNMT3A and DNMT3B act predominantly as the de novo methyltransferases, and create novel methylation patterns (11-13).In addition, DNA methylation and its regulatory enzymes have been implicated in a diverse set of biological processes, including X chromosome inactivation, genomic imprinting, as well as autoimmunity (14)(15)(16)(17). Mutation of the human DNMTs �l���� g��� �x�������� ��d ��� ���v�d� ����g�� ���� ��� �����-nism of various diseases, such as centromere instability, acute ���l��d l��k���� ��d ������d�fi������ (18�20). T��...